ClinicalTrials.govpublic full text
Poly(Ethylene Glycol)(PEG)-Asparaginase During Two Treatment Courses
acute lymphoblastic leukemia, asparaginase, intramuscular administration, silent antibodies, childhood acute lymphoblastic leukemia, side effects, 5-year efs, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 850807
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.